Efficacy and safety of larotrectinib in patients with TRK fusion cancer who had a long-term response

Authors

Publication/Presentation Date

9-2025

Volume

36

Issue

2

First Page

596

Last Page

597

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Share

COinS